 PLA2G7 siRNA |
|||
| 20-abx928801 | Abbexa |
|
|
PLA2G7 siRNA |
|||
| 20-abx928802 | Abbexa |
|
|
 PLA2G7 cloning plasmid |
|||
| CSB-CL623782HU-10ug | Cusabio | 10ug | EUR 233 |
|
Description: A cloning plasmid for the PLA2G7 gene. |
|||
 PLA2G7 Polyclonal Antibody |
|||
| A52996 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: reagents widely cited |
|||
PLA2G7 Polyclonal Antibody |
|||
| A55383 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: reagents widely cited |
|||
 PLA2G7 Rabbit pAb |
|||
| A13864-100ul | Abclonal | 100 ul | EUR 308 |
PLA2G7 Rabbit pAb |
|||
| A13864-200ul | Abclonal | 200 ul | EUR 459 |
PLA2G7 Rabbit pAb |
|||
| A13864-20ul | Abclonal | 20 ul | EUR 183 |
PLA2G7 Rabbit pAb |
|||
| A13864-50ul | Abclonal | 50 ul | EUR 223 |
 Anti-PLA2G7 antibody |
|||
| STJ111838 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene. |
|||
PLA2G7 Polyclonal Antibody |
|||
| 31737-100ul | SAB | 100ul | EUR 252 |
PLA2G7 Polyclonal Antibody |
|||
| 31737-50ul | SAB | 50ul | EUR 187 |
PLA2G7 Polyclonal Antibody |
|||
| 28385-100ul | SAB | 100ul | EUR 252 |
PLA2G7 Polyclonal Antibody |
|||
| 28385-50ul | SAB | 50ul | EUR 187 |
PLA2G7 Rabbit pAb |
|||
| A9796-100ul | Abclonal | 100 ul | EUR 308 |
PLA2G7 Rabbit pAb |
|||
| A9796-200ul | Abclonal | 200 ul | EUR 459 |
PLA2G7 Rabbit pAb |
|||
| A9796-20ul | Abclonal | 20 ul | EUR 183 |
PLA2G7 Rabbit pAb |
|||
| A9796-50ul | Abclonal | 50 ul | EUR 223 |
Anti-PLA2G7 antibody |
|||
| STJ115803 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene. |
|||
) PLA2G7 protein (His tag) |
|||
| 80R-4045 | Fitzgerald | 50 ug | EUR 435 |
|
Description: Recombinant Human PLA2G7 protein |
|||
 Human PLA2G7 ELISA Kit |
|||
| ELA-E0867h | Lifescience Market | 96 Tests | EUR 824 |
 Chicken PLA2G7 ELISA KIT |
|||
| ELI-02933c | Lifescience Market | 96 Tests | EUR 657 |
 Canine PLA2G7 ELISA KIT |
|||
| ELI-02934d | Lifescience Market | 96 Tests | EUR 928 |
 PLA2G7 Antibody, HRP conjugated |
|||
| 1-CSB-PA08917B0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against PLA2G7. Recognizes PLA2G7 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
 PLA2G7 Antibody, FITC conjugated |
|||
| 1-CSB-PA08917C0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against PLA2G7. Recognizes PLA2G7 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
 PLA2G7 Antibody, Biotin conjugated |
|||
| 1-CSB-PA08917D0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against PLA2G7. Recognizes PLA2G7 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
PLA2G7 Antibody, HRP conjugated |
|||
| 1-CSB-PA08919B0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against PLA2G7. Recognizes PLA2G7 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
PLA2G7 Antibody, FITC conjugated |
|||
| 1-CSB-PA08919C0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against PLA2G7. Recognizes PLA2G7 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
PLA2G7 Antibody, Biotin conjugated |
|||
| 1-CSB-PA08919D0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against PLA2G7. Recognizes PLA2G7 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
) PLA2G7 Recombinant Protein (Human) |
|||
| RP023686 | ABM | 100 ug | Ask for price |
) PLA2G7 Recombinant Protein (Mouse) |
|||
| RP162569 | ABM | 100 ug | Ask for price |
) PLA2G7 Recombinant Protein (Rat) |
|||
| RP220775 | ABM | 100 ug | Ask for price |
 Mouse PLA2G7 shRNA Plasmid |
|||
| 20-abx973852 | Abbexa |
|
|
 Anti-PAFAH/PLA2G7 Antibody |
|||
| A02164-2 | BosterBio | 100ug/vial | EUR 294 |
 Human PLA2G7 shRNA Plasmid |
|||
| 20-abx955323 | Abbexa |
|
|
) Polyclonal PLA2G7 Antibody (Center) |
|||
| APR06200G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PLA2G7 (Center). This antibody is tested and proven to work in the following applications: |
|||
 PLA2G7 Polyclonal Conjugated Antibody |
|||
| C28385 | SAB | 100ul | EUR 397 |
PLA2G7 Polyclonal Conjugated Antibody |
|||
| C31737 | SAB | 100ul | EUR 397 |
 (pORF)) Pla2g7 ORF Vector (Rat) (pORF) |
|||
| ORF073593 | ABM | 1.0 ug DNA | EUR 506 |
 (pORF)) PLA2G7 ORF Vector (Human) (pORF) |
|||
| ORF007896 | ABM | 1.0 ug DNA | EUR 95 |
 (pORF)) Pla2g7 ORF Vector (Mouse) (pORF) |
|||
| ORF054191 | ABM | 1.0 ug DNA | EUR 506 |
 PLA2G7 Polyclonal Antibody, Biotin Conjugated |
|||
| A52993 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: fast delivery possible |
|||
 PLA2G7 Polyclonal Antibody, FITC Conjugated |
|||
| A52994 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: reagents widely cited |
|||
 PLA2G7 Polyclonal Antibody, HRP Conjugated |
|||
| A52995 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
PLA2G7 Polyclonal Antibody, HRP Conjugated |
|||
| A55384 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
PLA2G7 Polyclonal Antibody, FITC Conjugated |
|||
| A55385 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: The best epigenetics products |
|||
PLA2G7 Polyclonal Antibody, Biotin Conjugated |
|||
| A55386 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: kits suitable for this type of research |
|||
 antibody) Anti-PLA2G7 (aa53-64) antibody |
|||
| STJ72956 | St John's Laboratory | 100 µg | EUR 260 |
 Polyclonal LP-PLA2 / PLA2G7 Antibody |
|||
| APR03221G | Leading Biology | 0.05ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LP-PLA2 / PLA2G7 . This antibody is tested and proven to work in the following applications: |
|||
 (OKCD01152)) PLA2G7 ELISA Kit (Human) (OKCD01152) |
|||
| OKCD01152 | Aviva Systems Biology | 96 Wells | EUR 792 |
|
Description: Description of target: Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids. ;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.286 ng/mL |
|||
 (OKBB01148)) PLA2G7 ELISA Kit (Human) (OKBB01148) |
|||
| OKBB01148 | Aviva Systems Biology | 96 Wells | EUR 505 |
|
Description: Description of target: Lipoprotein-associated phospholipase A2 (Lp-PLA2) also known as platelet-activating factor acetylhydrolase (PAF-AH) is a phospholipase A2 enzyme that in humans is encoded by the PLA2G7 gene. Lp-PLA2 is a 45-kDa protein of 441 amino acids. It is one of several PAF acetylhydrolases. The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: <20pg/ml |
|||
 (OKEH04385)) PLA2G7 ELISA Kit (Mouse) (OKEH04385) |
|||
| OKEH04385 | Aviva Systems Biology | 96 Wells | EUR 662 |
|
Description: Description of target: Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 39.2 pg/mL |
|||
 (OKCD06925)) PLA2G7 ELISA Kit (Mouse) (OKCD06925) |
|||
| OKCD06925 | Aviva Systems Biology | 96 Wells | EUR 779 |
|
Description: Description of target: Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 0.137ng/mL |
|||
 (OKCD06926)) PLA2G7 ELISA Kit (Rat) (OKCD06926) |
|||
| OKCD06926 | Aviva Systems Biology | 96 Wells | EUR 818 |
|
Description: Description of target: ;Species reactivity: Rat;Application: ELISA;Assay info: ;Sensitivity: < 5.1pg/mL |
|||
 (OKEH00643)) PLA2G7 ELISA Kit (Human) (OKEH00643) |
|||
| OKEH00643 | Aviva Systems Biology | 96 Wells | EUR 544 |
|
Description: Description of target: The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 23.4 pg/mL |
|||
